Summary & Overview
HCPCS S2400: Fetal Repair of Congenital Diaphragmatic Hernia with Tracheal Occlusion
HCPCS Level II code S2400 designates an in utero procedure to repair congenital diaphragmatic hernia (CDH) using temporary tracheal occlusion. This fetal surgical intervention aims to promote lung growth and improve neonatal outcomes for severe CDH cases. The code captures a highly specialized, resource-intensive service that is concentrated at tertiary fetal surgery centers and has implications for surgical, maternal-fetal medicine, and neonatology teams.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a national overview of clinical context and billing considerations tied to this procedure, including expected sites of service and the specialized nature of care. The publication outlines benchmarks where available, summarizes relevant policy or coverage themes that commonly affect high-acuity fetal interventions, and explains the coding context for payer negotiations and claim adjudication.
The content is intended to help billing managers, revenue cycle professionals, and clinical program leads understand how S2400 fits into service line planning and payer engagement for fetal surgery programs. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code S2400 describes the in utero repair of congenital diaphragmatic hernia using temporary tracheal occlusion. The procedure is performed on the fetus to address pulmonary hypoplasia and improve fetal lung development prior to birth.
Service Type: Fetal surgery / Maternal-fetal interventional procedure
Typical Site of Service: Hospital-based tertiary care center or specialized fetal surgery center (operating room or surgical suite within a hospital)
Clinical & Coding Specifications
Clinical Context
A pregnant patient at 24–30 weeks gestation is referred to a maternal-fetal medicine (MFM) program after prenatal imaging (high-resolution ultrasound and fetal MRI) demonstrates a large, left-sided congenital diaphragmatic hernia (CDH) with liver herniation and severe pulmonary hypoplasia risk. The multidisciplinary team includes MFM, pediatric surgery, neonatology, and anesthesiology. After counseling and review of fetal and maternal risks, the team elects to perform fetal repair via temporary tracheal occlusion (FETO) in utero to promote lung growth.
Procedure workflow:
-
Initial evaluation: detailed ultrasound, fetal echocardiography, fetal MRI, maternal labs, and consent discussions.
-
Preprocedure: maternal anesthesia planning, administration of prophylactic antibiotics and tocolysis as indicated, and ultrasound-guided fetal positioning.
-
Procedure: under maternal regional or general anesthesia, endoscopic fetoscopic insertion of a balloon device is performed and positioned in the fetal trachea to temporarily occlude the airway, stimulating lung growth. Imaging confirmation of balloon placement is obtained.
-
Postprocedure: maternal observation, ultrasound assessments to confirm balloon position and absence of immediate complications (e.g., preterm premature rupture of membranes, bleeding), and scheduled follow-up visits with serial imaging to monitor fetal lung growth.
-
Delivery planning: multidisciplinary delivery at a tertiary care center with immediate neonatal surgical-capable team prepared for balloon removal (if not spontaneously dislodged) and postnatal CDH repair planning.
Typical site of service: tertiary care hospital with maternal-fetal medicine and pediatric surgery/fetal surgery capabilities, operating room or specialized fetal intervention suite.
Typical patient scenario: a singleton pregnancy in the mid-second to early third trimester with sonographic and MRI confirmation of severe CDH and predicted poor pulmonary development, where temporary fetal tracheal occlusion is offered after multidisciplinary risk–benefit discussion.